Navigation Links
CNBC Features MMJ International Holdings on FDA, DEA Approved Marijuana Studies
Date:7/12/2019

Ted Danson on CNBC will be hosting an interview of the MMJ International Holdings executives focusing on scientific research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, scheduled to broadcast July 14, 2019 @ 1:30p.m. on CNBC. Check your local listings for more information.

With two investigational new drug applications already accepted by the FDA, MMJ International Holdings (MMJIH) is working to bring relief to patients suffering from Multiple Sclerosis and Huntington’s disease. This segment of advancements TV will focus on the science of medical cannabis and how our development of a pharmaceutical medicine of THC and cannabidiol, or CBD, is going to help people manage symptoms associated with Multiple Sclerosis, Huntington’s and other like neurological diseases.

“MMJ is excited to be part of this breakthrough episode of Advancements TV,” said CEO of MMJ International Holdings, Duane Boise. He continued, “We would like to commend the series on its vision and foresight in recognizing the need to educate audiences about the science of medical cannabis. MMJIH has always been an advocate for creating awareness about the value of marijuana-based pharmaceuticals. We believe that this industry is about to undergo a massive transformation and we are honored to be leader in the evolution of it.”

“MMJIH truly cares about helping people,” said Tim Moynahan, MMJIH Chairman “Using innovative technology, MMJ is helping to drastically cut drug development costs to obtain approval for an insurance reimbursable medicine. Patients are in need of a safe and effective marijuana-based pharmaceuticals to manage their unmet medical needs.”

About MMJIH:
MMJ International Holdings is dedicated to advancing the science of medical Cannabis. Having been awarded the FDA Orphan Designation, MMJIH is intent on bringing relief to patients around the world with its innovative and well FDA researched medical products. MMJ’s journey continues to prove the efficacy of cannabis as an FDA approved medicine while its unique scientific approach further distinguishes MMJ from others in the industry.

For more information, visit: http://www.mmjih.com.

Read the full story at https://www.prweb.com/releases/cnbc_features_mmj_international_holdings_on_fda_dea_approved_marijuana_studies/prweb16434134.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NEPC’s February Education Interview of the Month Features Discussion of Teachers as Brand Ambassadors
2. Clearskincare Cites Flexible Reporting Features For Switch to Zenoti
3. "Information Matrix", with Laurence Fishburne, Features a New Piece on Preventative Medicine
4. Provista Launches One-Stop Web Destination For Industry News, Features And Information
5. Nature Biotechnology Features ReadCoor as a 2016 Leading Spinout
6. Data4Cures AI-Powered Biomedical Intelligence Cloud Features New Tools for Multidimensional Disease Mapping and Immune-Oncology Research
7. Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA
8. CPhI SEA -- the leading pharma event in South East Asia - adds 6 new features
9. 2016 Continua Design Guidelines Include New Features For Simple Connectivity Of Personal Connected Health Devices
10. Excipient & Dosage Market Among Main Features of CPhI China 2016
11. CBS News Features Dr. Ashraf Hanna Describing How IV Ketamine is Successfully Treating Fibromyalgia Pain Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2020)... ... January 28, 2020 , ... According to the American Transplant Foundation, ... 30% will receive their life-saving surgery this year. Unfortunately, 20 people will die each ... 40,000. This is not from a lack of available donated organs, but mainly ...
(Date:1/28/2020)... ... January 28, 2020 , ... Knowing it can be difficult ... healthy changes, Isagenix International has launched several offerings, including Snack Bites, ... health and wellness company has also expanded its BEA™ Sparkling Energy Drink and ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... Once a ... speakers offer attendees their unique perspectives, innovative research and professional experiences, unmatched as a ... at the 34th annual iaedp™ Symposium slated for March 26 – 29, is no ...
Breaking Medicine Technology:
(Date:1/27/2020)... ... January 27, 2020 , ... Respected periodontists in Moorestown ... Pinnacle Dental Study Club course of the calendar year on January 29, 2020. The ... courses, hosted by the doctors at Canal Calem Periodontics. , The Pinnacle ...
(Date:1/27/2020)... ... 2020 , ... ConfiDenT is a trusted family, Alpharetta ... at 11550 Webb Bridge Way in Alpharetta, GA 30005, Dr. Cesar Tapia leads ... in general and preventative dentistry, as well as in restorative dentistry, cosmetic dentistry, ...
(Date:1/27/2020)... ... 26, 2020 , ... ResMed Launches AirFit F30i, Its First Tube-up Full Face ... the launch of the AirFit F30i, Its First Tube-up Full Face ResMed CPAP Mask. ... or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam ...
(Date:1/24/2020)... ... 24, 2020 , ... Primary Residential Mortgage, Inc. is pleased ... , PRMI was awarded second place in Springbuk’s annual Healthiest Employers awards ... adoption of programs that promote healthy lifestyles, such as biometric screenings, fitness and ...
(Date:1/24/2020)... ... 24, 2020 , ... The new strain of Wuhan coronavirus was first identified ... Thailand, Japan, and South Korea. The virus is believed to have started in the ... were infected. , EPA has confirmed that the 2019 novel coronavirus-Wuhan (also 2019-nCoV) ...
Breaking Medicine News(10 mins):